Archived documents
Documents past their public comment period for FDA.
FDA ▾
PSG_210745 - Draft Guidance on Apremilast
0 comments
Analysis in progress
Top issues in comments
PSG_202971 - Draft Guidance on Aripiprazole
0 comments
Analysis in progress
Top issues in comments
PSG_218643 - Draft Guidance on Articaine Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_219208 - Draft Guidance on Atrasentan Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_219616 - Draft Guidance on Avutometinib Potassium; Defactinib Hydrochloride
0 comments
Analysis in progress
Top issues in comments
PSG_207921 - Draft Guidance on Beclomethasone Dipropionate
0 comments
Analysis in progress
Top issues in comments
PSG_020911 - Draft Guidance on Beclomethasone Dipropionate
0 comments
Analysis in progress
Top issues in comments
PSG_216579 - Draft Guidance on Budesonide; Formoterol Fumarate
0 comments
Analysis in progress
Top issues in comments
PSG_021929 - Draft Guidance on Budesonide; Formoterol Fumarate Dihydrate
0 comments
Analysis in progress
Top issues in comments
PSG_212122 - Draft Guidance on Budesonide; Formoterol Fumarate; Glycopyrrolate
0 comments
Analysis in progress
Top issues in comments
PSG_209819 - Draft Guidance on Buprenorphine
0 comments
Analysis in progress
Top issues in comments
PSG_215499 - Draft Guidance on Cabotegravir
0 comments
Analysis in progress
Top issues in comments